ECLYPIA

Eclypia’s first product, NEOGLY®, places the company at the forefront of innovation. It is the result of a multidisciplinary and holistic approach to the challenges of non-invasive health monitoring. Advanced photonic chip and proprietary algorithms based on both physics and physiology measure the glucose levels in the body. Deep knowledge of physics and physiology were used to develop a digital twin and complex algorithms that can adapt to a variety of situations encountered in the real world. Quantum cascade lasers inside the wearable device illuminate the skin, and advanced electronics retrieve a signal, which is then decoded to calculate the glucose level in the skin. This is the first time quantum cascade lasers have ever been integrated into a wearable device. The device also contains photonic chips, electronics, algorithms, and other sensing modalities.